Ashika Maharaj

1.1k total citations · 1 hit paper
11 papers, 547 citations indexed

About

Ashika Maharaj is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ashika Maharaj has authored 11 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ashika Maharaj's work include Pancreatic and Hepatic Oncology Research (3 papers), Clinical practice guidelines implementation (3 papers) and Medical Malpractice and Liability Issues (2 papers). Ashika Maharaj is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Clinical practice guidelines implementation (3 papers) and Medical Malpractice and Liability Issues (2 papers). Ashika Maharaj collaborates with scholars based in Australia, New Zealand and United States. Ashika Maharaj's co-authors include Zanfina Ademi, Stella Talic, Xue Li, Ines Mesa‐Eguiagaray, Wei Xu, Xiaomeng Zhang, Evropi Τheodoratou, Dragan Ilić, Danijela Gašević and Holly Wild and has published in prestigious journals such as PLoS ONE, BMJ and BMC Health Services Research.

In The Last Decade

Ashika Maharaj

10 papers receiving 535 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis

2021 443 citations Stella Talic, Holly Wild et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashika Maharaj Australia	7	152	152	119	107	89	11	547
Stella Talic Australia	8	157 1.0×	155 1.0×	121 1.0×	76 0.7×	89 1.0×	23	599
Holly Wild Australia	4	157 1.0×	155 1.0×	118 1.0×	72 0.7×	81 0.9×	7	467
Ines Mesa‐Eguiagaray United Kingdom	10	152 1.0×	153 1.0×	130 1.1×	147 1.4×	93 1.0×	22	706
Wee Hoe Gan Singapore	11	88 0.6×	101 0.7×	143 1.2×	101 0.9×	89 1.0×	34	471
Elise Caruso United States	7	157 1.0×	243 1.6×	148 1.2×	80 0.7×	32 0.4×	11	505
Rachael M. Porter United States	8	131 0.9×	231 1.5×	218 1.8×	230 2.1×	171 1.9×	16	749
Karla Therese L. Sy United States	10	228 1.5×	203 1.3×	71 0.6×	56 0.5×	31 0.3×	22	560
Wafa Dhouib Tunisia	7	121 0.8×	132 0.9×	93 0.8×	47 0.4×	27 0.3×	34	395
Joshua Nazareth United Kingdom	8	92 0.6×	240 1.6×	157 1.3×	118 1.1×	28 0.3×	24	607
‏Yousef Alsofayan Saudi Arabia	11	105 0.7×	264 1.7×	89 0.7×	106 1.0×	26 0.3×	31	517

Countries citing papers authored by Ashika Maharaj

Since Specialization

Citations

This map shows the geographic impact of Ashika Maharaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashika Maharaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashika Maharaj more than expected).

Fields of papers citing papers by Ashika Maharaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashika Maharaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashika Maharaj. The network helps show where Ashika Maharaj may publish in the future.

Co-authorship network of co-authors of Ashika Maharaj

This figure shows the co-authorship network connecting the top 25 collaborators of Ashika Maharaj. A scholar is included among the top collaborators of Ashika Maharaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashika Maharaj. Ashika Maharaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Seddon, Mary, et al.. (2025). The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm. PubMed. 126(1368). 9–20.

Maharaj, Ashika, et al.. (2024). The use of patient reported outcome measures in oncology clinical practice across Australia and New Zealand. Journal of Patient-Reported Outcomes. 8(1). 1–1. 3 indexed citations

Ioannou, Liane, Ashika Maharaj, John Zalcberg, et al.. (2022). Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. HPB. 24(8). 1201–1216. 6 indexed citations

Ruseckaite, Rasa, Ashika Maharaj, Karolina Krysińska, et al.. (2022). Preliminary development of recommendations for the inclusion of patient-reported outcome measures in clinical quality registries. BMC Health Services Research. 22(1). 276–276. 17 indexed citations

Khan, Nadia, Ashika Maharaj, Sue Evans, et al.. (2022). A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer. BMC Health Services Research. 22(1). 213–213. 8 indexed citations

Talic, Stella, Holly Wild, Danijela Gašević, et al.. (2021). Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 375. e068302–e068302. 443 indexed citations breakdown →

Maharaj, Ashika, Sue Evans, John Zalcberg, et al.. (2020). Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. PLoS ONE. 15(12). e0243312–e0243312. 3 indexed citations

Maharaj, Ashika, Sue Evans, John Zalcberg, et al.. (2020). Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework. BMJ Quality & Safety. 30(10). 792–803. 16 indexed citations

Maharaj, Ashika, Sue Evans, John Zalcberg, et al.. (2019). Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. HPB. 22(2). 187–203. 23 indexed citations

10.

Ruseckaite, Rasa, et al.. (2019). <p>Developing a Preliminary Conceptual Framework for Guidelines on Inclusion of Patient Reported-Outcome Measures (PROMs) in Clinical Quality Registries</p>. Patient Related Outcome Measures. Volume 10. 355–372. 18 indexed citations

11.

Maharaj, Ashika, et al.. (2017). Medication-related patient harm in New Zealand hospitals.. PubMed. 130(1460). 21–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact